![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Pulmonary Fibrosis News Home | Pulmonary Fibrosis News
Jan 28, 2025 · Strategies that make exercise with pulmonary fibrosis easier for me. Exercise is important for people with chronic illness. But as someone living with idiopathic pulmonary fibrosis (IPF), a disease characterized by progressive scarring of the lungs and difficulty breathing, I know working out is easier said than done.
12 Facts About Pulmonary Fibrosis Prognosis and Life Expectancy
Aug 16, 2019 · To address some misconceptions about the prognosis of pulmonary fibrosis and life expectancy of patients, we’ve put together some frequently asked questions (and answers) to help:<. What causes pulmonary fibrosis? Some cases of pulmonary fibrosis occur without known cause (this is called idiopathic pulmonary fibrosis).Other cases are caused by exposure to environmental hazards (such as ...
New prototype therapy may repair IPF lung scarring by …
Apr 26, 2024 · The study provides pharmacological proof of concept for an upcoming Phase 1 clinical trial that’s evaluating CMR316, an investigational inhalable therapy similar to the designed prototype. “Most drugs act by slowing the progression of disease; our approach is to make drugs that control cell fate to stop or reverse the disease process,” Peter G. Schultz, PhD, president and CEO of Scripps ...
Pulmonary Fibrosis' End Stage: Wrestling with What to Expect
Nov 7, 2017 · One of my frustrations as a pulmonary fibrosis patient is finding solid information about what to expect as my PF progresses. I’ve asked several doctors what to expect during the end stage of PF, but often get the same answer: “We’re not there, no need to talk about that now.” I want to talk about the end stage
IPF Patients Live Longer on Ofev Compared with Placebo, Analysis …
Apr 16, 2019 · These trials demonstrated that treatment with Ofev could significantly prevent disease progression by slowing the rate of decline in forced vital capacity — a measure of lung function — in IPF patients. Although these studies were not designed to evaluate the impact of the treatment on a patient’s survival, the data suggested that Ofev could reduce the risk of death by 30% compared with ...
Pulmonary Fibrosis Symptoms, Diagnosis, Prognosis and Treatment
Recent Posts. Low cholesterol levels linked to worse outcomes in IPF: Study February 7, 2025; Strategies that make exercise with pulmonary fibrosis easier for me February 6, 2025; When we share our experiences with IPF, it’s not a competition February 4, 2025; Study uncovers why PF after severe COVID-19 doesn’t progress January 31, 2025; Dealing with grief is …
Ifetroban cleared to be tested in IPF patients in Phase 2 clinical ...
Jun 2, 2023 · The announcement follows the U.S. Food and Drug Administration (FDA) clearance of the company’s investigational new drug (IND) application — a formal request companies submit to regulatory agencies asking permission to start testing an investigational therapy in human trials.
Advice for Newly Diagnosed Patients - Pulmonary Fibrosis News
Feb 9, 2018 · I was diagnosed about a year ago just after retiring at age 58. In some ways I consider myself fortunate in that I was familiar with the disease because my mother had died six years previously at age 70 due to complications of cardiac arrest and pulmonary fibrosis.
Pulmonary Fibrosis Study Shows Enzyme Can Help Reverse Scarring
Feb 19, 2018 · The study dealt with the enzyme’s effect on myofibroblasts — cells involved in wound healing and inflammatory response. The discovery could lead to new therapies for the lung scarring disease pulmonary fibrosis and other fibrotic disorders, researchers said.
Pulmonary Fibrosis Ups Risk of Pneumonitis for Some With Lung …
Nov 27, 2018 · The study “ Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis ” was published in the journal Lung Cancer. Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck’s Keytruda (pembrolizumab) are two programmed death-1 (PD-1) immune checkpoint inhibitors designed to harness the immune system ...